[On hyperosmolar diabetic coma].
D007611:Aprotinin / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000378:metabolism; D003926:Diabetic Coma / Q000209:etiology* / Q000628:therapy; D016883:Diabetic Ketoacidosis / Q000150:complications; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D009994:Osmolar Concentration; D010646:Phentolamine / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D007328:Insulin; D010952:Plasma Substitutes; D014665:Vasodilator Agents; D007611:Aprotinin; D012964:Sodium; D011188:Potassium; D010646:Phentolamine
Considerazioni in tema di coma diabetico iperosmolare.